DelveInsight has launched a new report on “Generalized Pustular Psoriasis (GPP)-Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Generalized Pustular Psoriasis (GPP)–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Generalized Pustular Psoriasis (GPP), historical and forecasted epidemiology as well as the Generalized Pustular Psoriasis (GPP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
-
As per DelveInsight’s analysis, a higher percentage of diagnosed prevalence was observed for females, in comparison to males.
-
According to DelveInsight, the total diagnosed prevalent Population of GPP in the 7MM was assessed to be more than 14,000 in 2017.
-
Our estimates suggest the highest diagnosed prevalence of GPP in the United States with close to 6,000 cases in 2017. Furthermore, among the EU-5 countries, France had the highest diagnosed prevalent population of GPP, followed by Germany and the United Kingdom.
-
On the other hand, Spain was assessed with the lowest diagnosed prevalent population DelveInsight’s estimations showed that Japan had 2,602 prevalent cases for GPP in 2017
Key benefits of the report:
1.The Generalized Pustular Psoriasis (GPP) market report covers a descriptive overview and comprehensive insight of the Generalized Pustular Psoriasis (GPP) epidemiology and Generalized Pustular Psoriasis (GPP) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2.The Generalized Pustular Psoriasis (GPP) market report provides insights into the current and emerging therapies.
3.Generalized Pustular Psoriasis (GPP) market report provides a global historical and forecasted market covering drug outreach in 7MM.
4.The Generalized Pustular Psoriasis (GPP) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Generalized Pustular Psoriasis (GPP) market.
Request for sample pages: https://www.delveinsight.com/sample-request/generalized-pustular-psoriasis-market
Generalized Pustular Psoriasis (GPP): Overview
Generalized pustular psoriasis (GPP) is an extremely rare type of psoriasis that can present in a variety of forms. Unlike the most general and common forms of psoriasis, GPP usually covers the entire body and with pus-filled blisters rather than plaques. GPP can present at any age, but is rarer in young children.
The key players involved in the Generalized Pustular Psoriasis (GPP) market:
-
Janssen Pharmaceuticals
-
Novartis
-
Kyowa Hakko Kirin
-
AbbVie/Boehringer Ingelheim
-
AbbVie/Eisai
-
Eli Lilly & Company
-
Mitsubishi Tanabe Pharma
The launch of the emerging therapies is expected to significantly impact the Generalized Pustular Psoriasis (GPP) treatment scenario in the upcoming years:-
Drug covered
-
Tremfya
-
COSENTYX
-
Lumicef
-
Humira
-
Taltz
-
Remicade
Request a free sample report @https://www.delveinsight.com/sample-request/generalized-pustular-psoriasis-market
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Generalized Pustular Psoriasis (GPP) Patient Share (%) Overview at a Glance
5. Generalized Pustular Psoriasis (GPP) Market Overview at a Glance
6. Generalized Pustular Psoriasis (GPP) Disease Background and Overview
7. Generalized Pustular Psoriasis (GPP) Epidemiology and Patient Population
8. Country-Specific Patient Population of Generalized Pustular Psoriasis (GPP)
9. Generalized Pustular Psoriasis (GPP) Current Treatment and Medical Practices
10. Unmet Needs
11. Generalized Pustular Psoriasis (GPP) Emerging Therapies
12. Generalized Pustular Psoriasis (GPP) Market Outlook
13. Country-Wise Generalized Pustular Psoriasis (GPP) Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Generalized Pustular Psoriasis (GPP) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/